findmyKOL
Clinical trialNCT00804076CompletedPhase 1Interventional

Gene Transfer for Cancer Pain

SponsorDiamyd IncEnrollment10Cancer Pain
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary purpose of this study is to examine the safety of NP2 (a nonreplicating HSV-based vector expressing enkephalin) in patients with cancer pain. The secondary purpose is to evaluate efficacy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Advanced Pharma Cr

    Miami, Florida, United States

  • Louisiana Research Associates

    New Orleans, Louisiana, United States

  • University of Michigan Medical Center

    Ann Arbor, Michigan, United States

  • Center for Clinical Research

    Winston-Salem, North Carolina, United States

  • Pain Research of Oregon, Llc

    Eugene, Oregon, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NP2
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2008
Primary completion
30 Nov 2010
Completion
31 Jul 2013
Last update posted
19 Feb 2014
Registered enrollment
10
Registry id
NCT00804076
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.